Preparation, characterization and immune enhancement study of Hericium erinaceus polysaccharide‐loaded polyethyleneimine‐modified poly(lactic‐ co ‐glycolic acid) nanoparticles
Journal of the Science of Food and Agriculture · 30.08.2026 · 106 (11) · 6596-6605
DOI: 10.1002/jsfa.70690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Science of Food and Agriculture, online erschienen am 26.04.2026. Verfasst von Yong-Ming Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Key Laboratory of Neuropharmacology, Department of Pharmacy, Hebei North University, Zhangjiakou, China. Hauptthemen laut MEDLINE: Polyethyleneimine, Nanoparticles, Drug Carriers, Polysaccharides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Hericium erinaceus polysaccharides (HEPs) exhibit remarkable immunomodulatory properties but are hampered by poor oral bioavailability. To overcome these limitations, this study developed and optimized HEP‐loaded polyethyleneimine (PEI)‐modified poly(lactic‐ co ‐glycolic acid) (PLGA) nanoparticles (HEP‐PPNPs) as a novel drug delivery system. RESULTS Following formulation optimization, HEP‐PPNPs were successfully prepared using a modified double‐emulsion solvent evaporation method, achieving a high encapsulation efficiency of 71.78%. The prepared nanoparticles exhibited a spherical morphology with a mean particle size of 176.4 ± 3.6 nm, a narrow polydispersity index of 0.131 ± 0.005 and a positive zeta potential of +32.8 ± 0.3 mV. Biological assessments on RAW264.7 macrophages showed that HEP‐PPNPs significantly enhanced phagocytic activity and promoted the secretion of key immunomodulatory cytokines (TNF‐ α , IL‐6 and IL‐4) without cytotoxicity at effective concentrations. Furthermore, HEP‐PPNPs markedly upregulated the expression of co‐stimulatory molecules CD80 and CD86. The immunoenhancement effect of HEP‐PPNPs was significantly superior to that of both free HEPs and unmodified HEP‐PLGA nanoparticles. CONCLUSION The developed HEP‐PPNPs system effectively mitigates the pharmacokinetic limitations of native HEPs. The formulation demonstrates favorable physicochemical properties and elicits a stronger immunostimulatory response compared to the non‐encapsulated drug and its non‐cationic nanoparticle counterpart. This PEI‐modified nanoparticle platform represents a promising strategy for enhancing the oral therapeutic efficacy of HEPs. © 2026 Society of Chemical Industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hebei Key Laboratory of Neuropharmacology, Department of Pharmacy, Hebei North University, Zhangjiakou, China.
- Graduate School, Hebei North University, Zhangjiakou, China.
- Tianjin Beichen Traditional Chinese Medicine Hospital, Tianjin, China.
- Journal Editorial Office, Hebei North University, Zhangjiakou, China.
ORCID-Profile: Jin Wang
Zitieren
APA
Zhao, Y. M., Wang, M., Zhang, X. Y., Wang, J., & Wang, Y. Y. (2026). Preparation, characterization and immune enhancement study of Hericium erinaceus polysaccharide‐loaded polyethyleneimine‐modified poly(lactic‐ co ‐glycolic acid) nanoparticles. Journal of the Science of Food and Agriculture, 106(11), 6596-6605. https://doi.org/10.1002/jsfa.70690
Vancouver
Zhao YM, Wang M, Zhang XY, Wang J, Wang YY. Preparation, characterization and immune enhancement study of Hericium erinaceus polysaccharide‐loaded polyethyleneimine‐modified poly(lactic‐ co ‐glycolic acid) nanoparticles. Journal of the Science of Food and Agriculture. 2026;106(11):6596-6605. doi:10.1002/jsfa.70690
BibTeX
@article{Zhao2026,
author = {Zhao, Yong-Ming and Wang, Mai and Zhang, Xin-Yan and Wang, Jin and Wang, Yin-Yue},
title = {Preparation, characterization and immune enhancement study of Hericium erinaceus polysaccharide‐loaded polyethyleneimine‐modified poly(lactic‐ co ‐glycolic acid) nanoparticles},
journal = {Journal of the Science of Food and Agriculture},
year = {2026},
volume = {106},
number = {11},
pages = {6596--6605},
doi = {10.1002/jsfa.70690}
}
EUVIMED